Annual Cash & Cash Equivalents
$29.16 M
-$70.76 M-70.82%
December 1, 2023
Summary
- As of February 24, 2025, MAZE annual cash & cash equivalents is $29.16 million, with the most recent change of -$70.76 million (-70.82%) on December 1, 2023.
- During the last 3 years, MAZE annual cash & cash equivalents has fallen by -$70.76 million (-70.82%).
Performance
MAZE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$149.61 M
-$25.46 M-14.54%
September 1, 2024
Summary
- As of February 24, 2025, MAZE quarterly cash and cash equivalents is $149.61 million, with the most recent change of -$25.46 million (-14.54%) on September 1, 2024.
- Over the past year, MAZE quarterly cash and cash equivalents has dropped by -$25.46 million (-14.54%).
Performance
MAZE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MAZE Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -70.8% | -14.5% |
3 y3 years | -70.8% | -14.5% |
5 y5 years | -70.8% | -14.5% |
MAZE Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -70.8% | at low | -14.5% | -80.5% |
5 y | 5-year | -70.8% | at low | -14.5% | -80.5% |
alltime | all time | -70.8% | at low | -14.5% | -80.5% |
Maze Therapeutics Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $149.61 M(-14.5%) |
Jun 2024 | - | $175.06 M(+500.4%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | $29.16 M(-70.8%) | $29.16 M |
Dec 2022 | $99.92 M | - |
FAQ
- What is Maze Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Maze Therapeutics?
- What is Maze Therapeutics annual cash & cash equivalents year-on-year change?
- What is Maze Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Maze Therapeutics?
- What is Maze Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Maze Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of MAZE is $29.16 M
What is the all time high annual cash & cash equivalents for Maze Therapeutics?
Maze Therapeutics all-time high annual cash & cash equivalents is $99.92 M
What is Maze Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, MAZE annual cash & cash equivalents has changed by -$70.76 M (-70.82%)
What is Maze Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MAZE is $149.61 M
What is the all time high quarterly cash and cash equivalents for Maze Therapeutics?
Maze Therapeutics all-time high quarterly cash and cash equivalents is $175.06 M
What is Maze Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, MAZE quarterly cash and cash equivalents has changed by -$25.46 M (-14.54%)